Research
Print page Print page
Switch language
  1. Rigshospitalet
  2. Publications
  3. Pericardial Adipose Tissue Vol...
  4. Citationformats
Rigshospitalet - a part of Copenhagen University Hospital
Published

Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Knudsen, AD, Krebs-Demmer, L, Bjørge, NID, Elming, MB, Gelpi, M, Sigvardsen, PE, Lebech, A-M, Fuchs, A, KüHL, JT, Køber, L, Lundgren, J, Nordestgaard, BG, Kofoed, KF & Nielsen, SD 2020, 'Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir' The Journal of infectious diseases, vol. 222, no. 1, pp. 54-61. https://doi.org/10.1093/infdis/jiaa057

APA

Knudsen, A. D., Krebs-Demmer, L., Bjørge, N. I. D., Elming, M. B., Gelpi, M., Sigvardsen, P. E., ... Nielsen, S. D. (2020). Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir. The Journal of infectious diseases, 222(1), 54-61. https://doi.org/10.1093/infdis/jiaa057

CBE

Knudsen AD, Krebs-Demmer L, Bjørge NID, Elming MB, Gelpi M, Sigvardsen PE, Lebech A-M, Fuchs A, KüHL JT, Køber L, Lundgren J, Nordestgaard BG, Kofoed KF, Nielsen SD. 2020. Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir. The Journal of infectious diseases. 222(1):54-61. https://doi.org/10.1093/infdis/jiaa057

MLA

Knudsen, Andreas D et al. "Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir". The Journal of infectious diseases. 2020, 222(1). 54-61. https://doi.org/10.1093/infdis/jiaa057

Vancouver

Knudsen AD, Krebs-Demmer L, Bjørge NID, Elming MB, Gelpi M, Sigvardsen PE et al. Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir. The Journal of infectious diseases. 2020 Jun 16;222(1):54-61. https://doi.org/10.1093/infdis/jiaa057

Author

Knudsen, Andreas D ; Krebs-Demmer, Lisanne ; Bjørge, Natascha I D ; Elming, Marie B ; Gelpi, Marco ; Sigvardsen, Per E ; Lebech, Anne-Mette ; Fuchs, Andreas ; KüHL, Jørgen T ; Køber, Lars ; Lundgren, Jens ; Nordestgaard, Børge G ; Kofoed, Klaus F ; Nielsen, Susanne D. / Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir. In: The Journal of infectious diseases. 2020 ; Vol. 222, No. 1. pp. 54-61.

Bibtex

@article{e6597699c34d4865b18899d11860782f,
title = "Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir",
abstract = "BACKGROUND: Increased pericardial adipose tissue is associated with higher risk of cardiovascular disease. We aimed to determine whether human immunodeficiency virus (HIV) status was independently associated with larger pericardial adipose tissue volume and to explore possible HIV-specific risk factors.METHODS: Persons with HIV (PWH) were recruited from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study and matched 1:1 on age and sex to uninfected controls. Pericardial adipose tissue volume was measured using cardiac computed tomography.RESULTS: A total of 587 PWH and 587 controls were included. Median age was 52 years, and 88{\%} were male. Human immunodeficiency virus status was independently associated with 17 mL (95{\%} confidence interval [CI], 10-23; P < .001) larger pericardial adipose tissue volume. Larger pericardial adipose tissue volume was associated with low CD4+ nadir and prior use of stavudine, didanosine, and indinavir. Among PWH without thymidine analogue or didanosine exposure, time since initiating combination antiretroviral treatment (per 5-year use) was associated with l6 mL (95{\%} CI, -6 to -25; P = .002) lower pericardial adipose tissue volume.CONCLUSIONS: Human immunodeficiency virus status was independently associated with larger pericardial adipose tissue volume. Severe immunodeficiency, stavudine, didanosine, and indinavir were associated with larger pericardial adipose tissue volume. Persons with HIV with prior exposure to these drugs may constitute a distinct cardiovascular risk population.",
keywords = "cardiac computed tomography, comorbidity, HIV, obesity, pericardial fat, Pericardial fat, Obesity, Comorbidity, Cardiac computed tomography",
author = "Knudsen, {Andreas D} and Lisanne Krebs-Demmer and Bj{\o}rge, {Natascha I D} and Elming, {Marie B} and Marco Gelpi and Sigvardsen, {Per E} and Anne-Mette Lebech and Andreas Fuchs and K{\"u}HL, {J{\o}rgen T} and Lars K{\o}ber and Jens Lundgren and Nordestgaard, {B{\o}rge G} and Kofoed, {Klaus F} and Nielsen, {Susanne D}",
note = "{\circledC} The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.",
year = "2020",
month = "6",
day = "16",
doi = "10.1093/infdis/jiaa057",
language = "English",
volume = "222",
pages = "54--61",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "University of Chicago Press",
number = "1",

}

RIS

TY - JOUR

T1 - Pericardial Adipose Tissue Volume Is Independently Associated With Human Immunodeficiency Virus Status and Prior Use of Stavudine, Didanosine, or Indinavir

AU - Knudsen, Andreas D

AU - Krebs-Demmer, Lisanne

AU - Bjørge, Natascha I D

AU - Elming, Marie B

AU - Gelpi, Marco

AU - Sigvardsen, Per E

AU - Lebech, Anne-Mette

AU - Fuchs, Andreas

AU - KüHL, Jørgen T

AU - Køber, Lars

AU - Lundgren, Jens

AU - Nordestgaard, Børge G

AU - Kofoed, Klaus F

AU - Nielsen, Susanne D

N1 - © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

PY - 2020/6/16

Y1 - 2020/6/16

N2 - BACKGROUND: Increased pericardial adipose tissue is associated with higher risk of cardiovascular disease. We aimed to determine whether human immunodeficiency virus (HIV) status was independently associated with larger pericardial adipose tissue volume and to explore possible HIV-specific risk factors.METHODS: Persons with HIV (PWH) were recruited from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study and matched 1:1 on age and sex to uninfected controls. Pericardial adipose tissue volume was measured using cardiac computed tomography.RESULTS: A total of 587 PWH and 587 controls were included. Median age was 52 years, and 88% were male. Human immunodeficiency virus status was independently associated with 17 mL (95% confidence interval [CI], 10-23; P < .001) larger pericardial adipose tissue volume. Larger pericardial adipose tissue volume was associated with low CD4+ nadir and prior use of stavudine, didanosine, and indinavir. Among PWH without thymidine analogue or didanosine exposure, time since initiating combination antiretroviral treatment (per 5-year use) was associated with l6 mL (95% CI, -6 to -25; P = .002) lower pericardial adipose tissue volume.CONCLUSIONS: Human immunodeficiency virus status was independently associated with larger pericardial adipose tissue volume. Severe immunodeficiency, stavudine, didanosine, and indinavir were associated with larger pericardial adipose tissue volume. Persons with HIV with prior exposure to these drugs may constitute a distinct cardiovascular risk population.

AB - BACKGROUND: Increased pericardial adipose tissue is associated with higher risk of cardiovascular disease. We aimed to determine whether human immunodeficiency virus (HIV) status was independently associated with larger pericardial adipose tissue volume and to explore possible HIV-specific risk factors.METHODS: Persons with HIV (PWH) were recruited from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study and matched 1:1 on age and sex to uninfected controls. Pericardial adipose tissue volume was measured using cardiac computed tomography.RESULTS: A total of 587 PWH and 587 controls were included. Median age was 52 years, and 88% were male. Human immunodeficiency virus status was independently associated with 17 mL (95% confidence interval [CI], 10-23; P < .001) larger pericardial adipose tissue volume. Larger pericardial adipose tissue volume was associated with low CD4+ nadir and prior use of stavudine, didanosine, and indinavir. Among PWH without thymidine analogue or didanosine exposure, time since initiating combination antiretroviral treatment (per 5-year use) was associated with l6 mL (95% CI, -6 to -25; P = .002) lower pericardial adipose tissue volume.CONCLUSIONS: Human immunodeficiency virus status was independently associated with larger pericardial adipose tissue volume. Severe immunodeficiency, stavudine, didanosine, and indinavir were associated with larger pericardial adipose tissue volume. Persons with HIV with prior exposure to these drugs may constitute a distinct cardiovascular risk population.

KW - cardiac computed tomography

KW - comorbidity

KW - HIV

KW - obesity

KW - pericardial fat

KW - Pericardial fat

KW - Obesity

KW - Comorbidity

KW - Cardiac computed tomography

U2 - 10.1093/infdis/jiaa057

DO - 10.1093/infdis/jiaa057

M3 - Journal article

VL - 222

SP - 54

EP - 61

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 1

ER -

ID: 59288126